IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,258 | -51.4% | 276,393 | -24.8% | 0.01% | -30.0% |
Q2 2023 | $2,587 | -99.7% | 367,467 | +350.6% | 0.02% | +100.0% |
Q2 2022 | $900,000 | -76.6% | 81,549 | -64.7% | 0.01% | -64.3% |
Q1 2022 | $3,847,000 | +3495.3% | 231,077 | +4008.0% | 0.03% | +2700.0% |
Q4 2021 | $107,000 | -76.8% | 5,625 | -70.0% | 0.00% | -50.0% |
Q3 2021 | $462,000 | -21.7% | 18,728 | -17.4% | 0.00% | -33.3% |
Q2 2021 | $590,000 | -19.0% | 22,671 | -1.4% | 0.00% | -25.0% |
Q1 2021 | $728,000 | +108.6% | 22,989 | +205.3% | 0.00% | +100.0% |
Q4 2020 | $349,000 | -70.6% | 7,531 | -79.2% | 0.00% | -75.0% |
Q3 2020 | $1,189,000 | +560.6% | 36,133 | +449.7% | 0.01% | +700.0% |
Q2 2020 | $180,000 | -77.9% | 6,573 | -75.8% | 0.00% | -87.5% |
Q1 2020 | $814,000 | +36.6% | 27,206 | +26.4% | 0.01% | +60.0% |
Q4 2019 | $596,000 | +66.5% | 21,516 | +9.3% | 0.01% | +66.7% |
Q3 2019 | $358,000 | -89.2% | 19,691 | -85.4% | 0.00% | -87.0% |
Q2 2019 | $3,313,000 | +402.7% | 135,101 | +95.0% | 0.02% | +283.3% |
Q1 2019 | $659,000 | +266.1% | 69,269 | +241.2% | 0.01% | +200.0% |
Q4 2018 | $180,000 | +53.8% | 20,301 | +122.7% | 0.00% | +100.0% |
Q2 2018 | $117,000 | -45.8% | 9,116 | -28.6% | 0.00% | -50.0% |
Q1 2018 | $216,000 | -44.6% | 12,776 | -74.6% | 0.00% | -33.3% |
Q3 2017 | $390,000 | +413.2% | 50,295 | +385.3% | 0.00% | +200.0% |
Q2 2017 | $76,000 | – | 10,364 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |